{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:34:30Z","timestamp":1784010870952,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.idc.2023.12.005","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T01:24:43Z","timestamp":1706232283000},"page":"35-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Role of Biomarkers in the Diagnosis and Management of Pneumonia"],"prefix":"10.1016","volume":"38","author":[{"given":"Sarah","family":"Sungurlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idc.2023.12.005_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A\u00a0prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib2","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QCO.0000000000000351","article-title":"Duration of pneumonia therapy and the role of biomarkers","volume":"30","author":"Kaziani","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"17","key":"10.1016\/j.idc.2023.12.005_bib6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11908-014-0430-0","article-title":"Ventilator-associated conditions versus ventilator-associated pneumonia: different by design","volume":"16","author":"Klompas","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"11","key":"10.1016\/j.idc.2023.12.005_bib8","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/CCM.0b013e3182a262db","article-title":"Developing a\u00a0new, national approach to surveillance for ventilator-associated events\u2217","volume":"41","author":"Magill","year":"2013","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1378\/chest.08-1617","article-title":"Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes","volume":"135","author":"Craven","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.idc.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc6890","article-title":"Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","volume":"12","author":"Nseir","year":"2008","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2023.12.005_bib11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ijantimicag.2015.10.012","article-title":"Procalcitonin to guide antibiotic therapy in the ICU","volume":"46","author":"Brechot","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa031544","article-title":"Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia","volume":"350","author":"Gibot","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.2102084","article-title":"Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria","volume":"166","author":"Angus","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.idc.2023.12.005_bib14","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1097\/CCM.0b013e3181b02dbb","article-title":"Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia","volume":"37","author":"Renaud","year":"2009","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.idc.2023.12.005_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/09031936.06.00062505","article-title":"Validation of a predictive rule for the management of community-acquired pneumonia","volume":"27","author":"Capelastegui","year":"2006","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.idc.2023.12.005_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.200602-177OC","article-title":"Development and validation of a clinical prediction rule for severe community-acquired pneumonia","volume":"174","author":"Espana","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/JCM.00655-10","article-title":"Use of plasma procalcitonin levels as an adjunct to clinical microbiology","volume":"48","author":"Gilbert","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17476348.2.5.565","article-title":"Biomarkers in the management of pneumonia","volume":"2","author":"Christ-Crain","year":"2008","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.idc.2023.12.005_bib20","series-title":"Critical care medicine: principles of diagnosis and management in the adult","first-page":"1","article-title":"Pneumonia: considerations for the critically ill patient","author":"Nair","year":"2013"},{"issue":"3","key":"10.1016\/j.idc.2023.12.005_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrc.2010.10.007","article-title":"Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia","volume":"26","author":"Lee","year":"2011","journal-title":"J\u00a0Crit Care"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1469-0691.2004.01044.x","article-title":"C-reactive protein as a marker of infection in critically ill patients","volume":"11","author":"Povoa","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2023.12.005_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1378\/chest.15-1703","article-title":"Lactic acidosis in sepsis: it\u2019s not all anaerobic: implications for diagnosis and management","volume":"149","author":"Suetrong","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.idc.2023.12.005_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00134-008-1088-6","article-title":"Biomarkers in the diagnosis of pneumonia in the critically ill: don\u2019t shoot the piano player","volume":"34","author":"Ewig","year":"2008","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.idc.2023.12.005_bib25","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/CCM.0b013e3181f17bf9","article-title":"Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Kopterides","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.005_bib26","first-page":"578","article-title":"Biomarkers to improve diagnostic and prognostic accuracy in systemic infections","volume":"13","author":"Schuetz","year":"2007","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/eri.10.25","article-title":"Procalcitonin for guidance of antibiotic therapy","volume":"8","author":"Schuetz","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.idc.2023.12.005_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.62.4.337","article-title":"Can Procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?","volume":"62","author":"Delevaux","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.idc.2023.12.005_bib30","first-page":"205","article-title":"Differential Diagnosis of acute rejection and infection with procalcitonin and cytokines","volume":"1","author":"Staehler","year":"1997","journal-title":"Langenbecks Arch Chir"},{"key":"10.1016\/j.idc.2023.12.005_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF01713044","article-title":"Procalcitonin in patients with and without immunosuppression and sepsis","volume":"24","author":"Al Nawas","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.idc.2023.12.005_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/CCM.0b013e3181692966","article-title":"Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery","volume":"36","author":"Amour","year":"2008","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.00054507","article-title":"Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes","volume":"31","author":"Kruger","year":"2008","journal-title":"The Eur Respir J"},{"issue":"5","key":"10.1016\/j.idc.2023.12.005_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study","volume":"45","author":"Schuetz","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2023.12.005_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.12.005_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.06.00005606","article-title":"Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections","volume":"28","author":"Phua","year":"2006","journal-title":"The Eur Respir J"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/thx.2009.134072","article-title":"Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis","volume":"65","author":"Loke","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib38","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"Ramirez","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.005_bib39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1378\/chest.11-2430","article-title":"Role of procalcitonin in managing adult patients with respiratory tract infections","volume":"141","author":"Schuetz","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.idc.2023.12.005_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chest.2016.04.010","article-title":"Procalcitonin as an early marker of the need for invasive respiratory or vasopressor support in adults with community-acquired pneumonia","volume":"150","author":"Self","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2023.12.005_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.200406-746OC","article-title":"Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia","volume":"171","author":"Luyt","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2023.12.005_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"The Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2023.12.005_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2013.697","article-title":"Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections","volume":"309","author":"Schuetz","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2023.12.005_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13613-017-0338-6","article-title":"Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis","volume":"7","author":"Huang","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib45","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2023.12.005_bib46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/CCM.0000000000002953","article-title":"Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies","volume":"46","author":"Lam","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.005_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/CCM.0000000000002928","article-title":"Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis","volume":"46","author":"Iankova","year":"2018","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.idc.2023.12.005_bib48","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/jgs.14894","article-title":"Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia","volume":"65","author":"Cataudella","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.idc.2023.12.005_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1378\/chest.08-1981","article-title":"Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia","volume":"136","author":"Huang","year":"2009","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib50","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00134-015-3955-2","article-title":"Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"41","author":"Gu","year":"2015","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.idc.2023.12.005_bib51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajem.2015.12.067","article-title":"Validation of modified early warning score using serum lactate level in community-acquired pneumonia patients. The National Early Warning Score-Lactate score","volume":"34","author":"Jo","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.idc.2023.12.005_bib52","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","article-title":"Procalcitonin increase in early identification of critically ill patients at high risk of mortality","volume":"34","author":"Jensen","year":"2006","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2023.12.005_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.00035610","article-title":"Prognostic value of procalcitonin in community-acquired pneumonia","volume":"37","author":"Schuetz","year":"2011","journal-title":"Eur Respir J"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:14Z","timestamp":1760196734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552023000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0891552023000910"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2023.12.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Biomarkers in the Diagnosis and Management of Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}